Patients with persistent/permanent AF were not included in this study because we wanted to study if apelin is reduced in the setting of paroxysmal AF and therefore if it potentially can be used for AF detection (e.g., in patients after cryptogenic stroke with no symptoms of arrhythmia). This evidence concerns the gene APLN and Arrhythmia.